Schedule 14D-9: The Target Board's Tender Reply

Key Takeaways

• Schedule 14D-9 is the target board's formal response to a tender offer.
• It must be filed within 10 business days of the offer's commencement.
• The board can recommend tendering, recommend against it, or take no position.
• The background section and any fairness opinion reveal how the board reached its view.

What It Is

Schedule 14D-9 is the solicitation/recommendation statement required under Rule 14d-9 of the Securities Exchange Act. It is the answer to a bidder's Schedule TO, filed by the company being targeted rather than the company making the offer.

The form, formally Schedule 14D-101, requires the target's board to state its position on the offer and the reasons for it. Without this filing, shareholders would hear only the bidder's case and have no independent view from the people who run the company they own.

The Intuition

A tender offer puts each shareholder in the position of deciding whether to sell. The bidder, naturally, presents the offer favorably. Shareholders need a counterweight: an informed assessment from a party with a duty to act in their interest.

That is the role of the board. Directors have access to internal projections, strategy, and often a financial advisor's analysis. Rule 14d-9 requires them to share their conclusion and the basis for it, so shareholders can weigh the offer against management's own view of the company's worth.

How It Works

The target must file Schedule 14D-9 within 10 business days of the tender offer's commencement. The filing states the board's position, which can take one of several forms.

• A recommendation that shareholders accept the offer and tender their shares
• A recommendation that shareholders reject the offer and not tender
• A statement that the board expresses no opinion and is neutral
• A statement that the board is unable to take a position at this time

Whichever it chooses, the board must explain its reasons, including why it cannot take a position if that is the case. The statement typically includes a background section narrating the contacts and negotiations with the bidder, a discussion of the factors the board weighed, and often a fairness opinion from an investment bank assessing whether the price is fair to shareholders.

The filing also discloses conflicts of interest, such as change-in-control payments to executives, and any defensive measures the board has in place, such as a shareholder rights plan. These details let holders judge whether the recommendation is driven by shareholder value or by management self-interest.

Worked Example

Suppose a bidder launches a tender offer at 30 dollars per share through a Schedule TO. The target's board hires a financial advisor and reviews the offer.

Within 10 business days, the board files a Schedule 14D-9 recommending that shareholders reject the offer. The background section describes how the board countered with internal projections suggesting standalone value above 35 dollars. The fairness opinion concludes the 30 dollar price is inadequate.

A shareholder reads both filings together. The bidder's Schedule TO frames 30 dollars as a generous premium, while the 14D-9 argues the company is worth more alone. The holder also checks the conflicts section and sees that executives would receive large severance if the deal closed, which colors how much weight to give the rejection.

Common Mistakes

1. Taking the recommendation at face value. A board can have its own incentives. Change-in-control payouts or entrenchment motives can shape a recommendation, so the reasoning matters more than the conclusion.

2. Skipping the background section. The narrative of how negotiations unfolded often reveals whether the board genuinely shopped the company or rejected a fair offer reflexively.

3. Ignoring the fairness opinion's limits. A fairness opinion says a price is within a reasonable range, not that it is the best possible price. Reading it as a precise valuation overstates what it provides.

4. Overlooking defensive measures. The 14D-9 discloses poison pills and other defenses. A board recommending rejection while sitting on strong takeover defenses can block an offer shareholders might prefer.

5. Confusing it with the bidder's filing. Schedule 14D-9 is the target's response. The offer terms live in the bidder's Schedule TO. You need both to evaluate a tender offer properly.

Frequently Asked Questions

What is a Schedule 14D-9 recommendation in simple terms? A Schedule 14D-9 recommendation is the target board's official response to a tender offer, telling shareholders whether to accept, reject, or wait. It explains the board's reasoning and any conflicts.

How does a Schedule 14D-9 recommendation affect investment decisions? The board's position and its fairness opinion give you an informed counterpoint to the bidder's pitch, which directly shapes the decision to tender or hold. Checking the conflicts and defensive measures helps you judge whether the recommendation truly serves shareholders.

What is a real-world example of a Schedule 14D-9 recommendation? A board facing a 30 dollar tender offer files a Schedule 14D-9 recommending rejection, citing internal projections and a fairness opinion that the price undervalues the company.

How can investors read a Schedule 14D-9 recommendation effectively? Read the background section and the conflicts disclosure alongside the recommendation, and treat the fairness opinion as a range rather than a precise value. Always pair it with the bidder's Schedule TO.

How is a Schedule 14D-9 different from a Schedule TO? Schedule TO is filed by the bidder to make and disclose the tender offer, while Schedule 14D-9 is filed by the target company's board to give its recommendation in response.

Sources

1. Cornell Legal Information Institute. 17 CFR 240.14d-9, Recommendation or solicitation by the subject company and others. https://www.law.cornell.edu/cfr/text/17/240.14d-9
2. SEC. Tender Offer Rules and Schedules. https://www.sec.gov/rules-regulations/staff-guidance/corporation-finance-interpretations/tender-offer-rules-schedules
3. Cornell Legal Information Institute. 17 CFR 240.14d-101, Schedule 14D-9. https://www.law.cornell.edu/cfr/text/17/240.14d-101
4. Harvard Law School Forum on Corporate Governance. Going Private Transactions. https://corpgov.law.harvard.edu/2020/04/18/going-private-transactions/

Disclaimer

This article is educational content only and is not financial advice. Nothing here is a recommendation to buy, sell, or hold any security. Consult a licensed advisor before making investment decisions.